Status:
COMPLETED
Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Cystic Fibrosis Foundation
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
10+ years
Brief Summary
Clinical and translational research in cystic fibrosis (CF) is hampered by a lack of biomarkers that can be used to identify promising new therapies. There is an urgent need for development and valida...
Eligibility Criteria
Inclusion
- Diagnosis of CF as evidenced by a sweat chloride test \>60mEq/L or by the presence of two known CF genetic mutations
- Male or female greater than or equal to 10 years of age
- Initiation of intravenous antibiotic therapy for a clinically diagnosed acute pulmonary exacerbation
- Ability to perform reproducible pulmonary function tests
- Willing to comply with the study procedures and willingness to provide written consent
Exclusion
- Presence of a condition or abnormality that, in the opinion of the Principal Investigator (PI), would compromise the safety of the patient or quality of the data
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT00788359
Start Date
December 1 2007
End Date
July 1 2014
Last Update
December 2 2014
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Medical and Research Center
Denver, Colorado, United States, 80206
2
Riley Hospital for Children
Indianapolis, Indiana, United States, 46202
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
4
Case Western Reserve University
Cleveland, Ohio, United States, 44106